134 related articles for article (PubMed ID: 30929573)
21. Peroxisome proliferator-activated receptor gamma expression in follicular-patterned thyroid lesions. Caveats for the use of immunohistochemical studies.
Gustafson KS; LiVolsi VA; Furth EE; Pasha TL; Putt ME; Baloch ZW
Am J Clin Pathol; 2003 Aug; 120(2):175-81. PubMed ID: 12931546
[TBL] [Abstract][Full Text] [Related]
22. Clear Cell Variant of a Follicular Thyroid Tumor With Uncertain Malignant Potential: A Case Report.
Juhlin CC; Bränström R; Shabo I; Höög A
Int J Surg Pathol; 2019 May; 27(3):290-293. PubMed ID: 30370813
[TBL] [Abstract][Full Text] [Related]
23. [HBME-1 and cyclin D1 as diagnostic markers for follicular thyroid carcinoma].
Moyano L; Franco C; Carreño L; Robinson P; Sánchez G
Rev Med Chil; 2004 Mar; 132(3):279-84. PubMed ID: 15376563
[TBL] [Abstract][Full Text] [Related]
24. Can noninvasive follicular thyroid neoplasm with papillary-like nuclear features be distinguished from classic papillary thyroid carcinoma and follicular adenomas by fine-needle aspiration?
Brandler TC; Zhou F; Liu CZ; Cho M; Lau RP; Simsir A; Patel KN; Sun W
Cancer Cytopathol; 2017 Jun; 125(6):378-388. PubMed ID: 28296267
[TBL] [Abstract][Full Text] [Related]
25. Value of thyroid specific peroxidase and Ki-67 stains in preoperative cytology for thyroid follicular tumors.
Maruta J; Hashimoto H; Yamashita H; Noguchi H; Noguchi S; Kobayashi TK; Tsuneoka H; Takahashi M
Diagn Cytopathol; 2015 Mar; 43(3):202-9. PubMed ID: 25195571
[TBL] [Abstract][Full Text] [Related]
26. p53 protein, PCNA staining, and DNA content in follicular neoplasms of the thyroid gland.
Czyz W; Joensuu H; Pylkkänen L; Klemi PJ
J Pathol; 1994 Dec; 174(4):267-74. PubMed ID: 7884588
[TBL] [Abstract][Full Text] [Related]
27. DNA Methylation Haplotype Block Markers Efficiently Discriminate Follicular Thyroid Carcinoma from Follicular Adenoma.
Zhang H; Zhang Z; Liu X; Duan H; Xiang T; He Q; Su Z; Wu H; Liang Z
J Clin Endocrinol Metab; 2021 Mar; 106(4):1011-1021. PubMed ID: 33394038
[TBL] [Abstract][Full Text] [Related]
28. Trefoil factor 3 (TFF3): a promising indicator for diagnosing thyroid follicular carcinoma.
Takano T; Yamada H
Endocr J; 2009; 56(1):9-16. PubMed ID: 18506086
[TBL] [Abstract][Full Text] [Related]
29. Classification of follicular thyroid tumors by molecular signature: results of gene profiling.
Barden CB; Shister KW; Zhu B; Guiter G; Greenblatt DY; Zeiger MA; Fahey TJ
Clin Cancer Res; 2003 May; 9(5):1792-800. PubMed ID: 12738736
[TBL] [Abstract][Full Text] [Related]
30. A comparative study of flow cytometry and histopathologic findings in thyroid follicular carcinomas and adenomas.
Oyama T; Vickery AL; Preffer FI; Colvin RB
Hum Pathol; 1994 Mar; 25(3):271-5. PubMed ID: 8150457
[TBL] [Abstract][Full Text] [Related]
31. Expression pattern of p53-binding protein 1 as a new molecular indicator of genomic instability in bladder urothelial carcinoma.
Matsuda K; Kawasaki T; Akazawa Y; Hasegawa Y; Kondo H; Suzuki K; Iseki M; Nakashima M
Sci Rep; 2018 Oct; 8(1):15477. PubMed ID: 30341375
[TBL] [Abstract][Full Text] [Related]
32. Clinical application of human telomerase reverse transcriptase gene expression in thyroid follicular tumors by fine-needle aspirations using in situ hybridization.
Kammori M; Nakamura K; Hashimoto M; Ogawa T; Kaminishi M; Takubo K
Int J Oncol; 2003 May; 22(5):985-91. PubMed ID: 12684663
[TBL] [Abstract][Full Text] [Related]
33. [Aspiration biopsy-nucleic acid diagnosis for widely used preparative testing].
Takano T
Rinsho Byori; 2012 Feb; 60(2):132-8. PubMed ID: 22568094
[TBL] [Abstract][Full Text] [Related]
34. Artificial neural network model to distinguish follicular adenoma from follicular carcinoma on fine needle aspiration of thyroid.
Savala R; Dey P; Gupta N
Diagn Cytopathol; 2018 Mar; 46(3):244-249. PubMed ID: 29266871
[TBL] [Abstract][Full Text] [Related]
35. PD-L1 and thyroid cytology: A possible diagnostic and prognostic marker.
Dell'Aquila M; Granitto A; Martini M; Capodimonti S; Cocomazzi A; Musarra T; Fiorentino V; Pontecorvi A; Lombardi CP; Fadda G; Pantanowitz L; Larocca LM; Rossi ED
Cancer Cytopathol; 2020 Mar; 128(3):177-189. PubMed ID: 31821747
[TBL] [Abstract][Full Text] [Related]
36. Role of GPER1, EGFR and CXCR1 in differentiating between malignant follicular thyroid carcinoma and benign follicular thyroid adenoma.
Zhao L; Zhu XY; Jiang R; Xu M; Wang N; Chen GG; Liu ZM
Int J Clin Exp Pathol; 2015; 8(9):11236-47. PubMed ID: 26617848
[TBL] [Abstract][Full Text] [Related]
37. Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma.
Tan A; Etit D; Bayol U; Altinel D; Tan S
Ann Diagn Pathol; 2011 Apr; 15(2):108-16. PubMed ID: 21315633
[TBL] [Abstract][Full Text] [Related]
38. Ki-67 and AgNOR proliferative markers as diagnostic adjuncts to fine needle aspiration cytology of thyroid follicular lesions.
Mehrotra A; Goel MM; Singh K
Anal Quant Cytol Histol; 2002 Aug; 24(4):205-11. PubMed ID: 12199321
[TBL] [Abstract][Full Text] [Related]
39. Is atypical follicular adenoma of the thyroid a preinvasive malignancy?
Tzen CY; Huang YW; Fu YS
Hum Pathol; 2003 Jul; 34(7):666-9. PubMed ID: 12874762
[TBL] [Abstract][Full Text] [Related]
40. Biological differential diagnosis of follicular thyroid tumor and Hürthle cell tumor on the basis of telomere length and hTERT expression.
Sugishita Y; Kammori M; Yamada O; Yamazaki K; Ito K; Fukumori T; Yoshikawa K; Yamada T
Ann Surg Oncol; 2014 Jul; 21(7):2318-25. PubMed ID: 24562933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
